Phase III Study of Pemetrexed Plus Carboplatin Compared With Etoposide Plus Carboplatin in Chemotherapy-Naive Patients With Extensive-Stage Small-Cell Lung Cancer
MA Socinski, EF Smit, P Lorigan, K Konduri, M Reck, A Szczesna, J Blakely, P Serwatowski, NA Karaseva, T Ciuleanu, J Jassem, M Dediu, S Hong, C Visseren-Grul, A-R Hanauske, CK Obasaju, SC Guba, N Thatcher
Phase III Study of Pemetrexed Plus Carboplatin Compared With Etoposide Plus Carboplatin in Chemotherapy-Naive Patients With Extensive-Stage Small-Cell Lung Cancer
J Clin Oncol. 2009 Aug 31; Epub ahead of print, MA Socinski, EF Smit, P Lorigan, K Konduri, M Reck, A Szczesna, J Blakely, P Serwatowski, NA Karaseva, T Ciuleanu, J Jassem, M Dediu, S Hong, C Visseren-Grul, A-R Hanauske, CK Obasaju, SC Guba, N Thatcher
ABSTRACT
This randomized phase III study of patients with extensive-stage SCLC was closed early when an interim analysis showed that pemetrexed-carboplatin was inferior to standard treatment, etoposide-carboplatin,...
